Similar Items: Identifying novel drugs for the treatment of rhabdomyosarcoma
- The role of T-box transcription factor TBX3 in rhabdomyosarcoma
- Identifying the molecular basis for treatment resistance in a subset of myasthenia gravis patients of African ancestory
- Modulation of the progesterone receptor by progestogens, antiretroviral drugs and the glucocorticoid receptor
- Melanocyte survival and response to treatment in Vitiligo Patients
- P450 biochips : development of a protein microarray platform for investigating cytochrome P450 clinical drug metabolism
- Functional Analysis of the Novel Stress- Inducible XVPSAP promoter isolated from Xerophya Viscosa
Author: Prince, Sharon
- Identification and characterization of a novel Palladacycle, AJ-5, to treat advanced Melanoma and breast Cancer
- The role of TBX2 and the anti-cancer activity of chromomycin A5 in pancreatic ductal adenocarcinoma
- The role of the transcription factor TBX2 in breast cancer and melanoma and its regulation by the UV-induced DNA damage pathway.
- Regulation of the cyclin-dependent kinase inhibitor p21 by TBX3
- Identifying novel drugs for the treatment of rhabdomyosarcoma
- The role of T-box transcription factor TBX3 in rhabdomyosarcoma